How the Navadurga Protect Bhaktapur. The Effective Meanings of a Symbolic Enactment in Heritage of the Kathmandu ValleyLEVY, R. I.Proccedings of an International Conférence. 1987, pp 107-134, isbn 3-88280-029-1, isbn 3-88280-029-1Conference Proceedings

The mechanisms of action of lipid-lowering drugsLEVY, R. I.Cardiovascular reviews & reports. 1991, Vol 12, Num 11, pp 46-48, issn 0197-3118Article

Lipid regulation: a new era in the prevention of coronary heart disease. Symposium, November 11, 1984 Miami Beach FLLEVY, R. I.The American heart journal. 1986, Vol 112, Num 2, pp 431-440, issn 0002-8703Conference Proceedings

Therapy for hypercholesterolemia: standardization of cholesterol measurementsHAMBURGER, J. I; HASSEMER, D. J; WIEBE, D. A et al.JAMA, the journal of the American Medical Association. 1990, Vol 263, Num 3, pp 375-376, issn 0098-7484Article

Pathogenesis and management of lipoprotein disordersSCHAEFER, E. J; LEVY, R. I.The New England journal of medicine. 1985, Vol 312, Num 20, pp 1300-1310, issn 0028-4793Article

Secondary prevention and lipid lowering: results and implicationsDETRE, K. M; LEVY, R. I; BATTAGLINI, J. W et al.The American heart journal. 1985, Vol 110, Num 5, pp 1123-1127, issn 0002-8703Article

The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal femalesSCHAEFER, E. J; FOSTER, D. M; ZECH, L. A et al.The Journal of clinical endocrinology and metabolism. 1983, Vol 57, Num 2, pp 262-267, issn 0021-972XArticle

Current therapy for hypercholesterolemiaBLUM, C. B; LEVY, R. I.JAMA, the journal of the American Medical Association. 1989, Vol 261, Num 24, pp 3582-3587, issn 0098-7484Article

Proceedings/Lipoproteins and atherosclerosis, joint U.S.-U.S.S.R. symposium, September 22-23, 1986, Bethesda, MD, USALEVY, R. I; KLIMOV, A. N; SMIRNOV, V. N et al.Atherosclerosis reviews. 1988, Vol 17, issn 0362-1650, XXI-311 pConference Proceedings

Role of dietary intervention in the primary prevention of coronary heart disease: individuals with high-normal or elevated serum cholesterol levels should be placed on cholesterol-lowering dietsBLUM, C. B; LEVY, R. I.Cardiology. 1987, Vol 74, Num 1, pp 2-21, issn 0008-6312Article

IAIMS at Columbia: a strategic plan and model projectHENDRICKSON, G. L. F; GOLDSTEIN ANDERSON, R. K; LEVY, R. I et al.Bulletin of the Medical Library Association. 1986, Vol 74, Num 3, pp 243-248, issn 0025-7338Article

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI type II coronary intervention studyLEVY, R. I; BRENSIKE, J. F; MORIARTY, D. J et al.Circulation (New York, N.Y.). 1984, Vol 69, Num 2, pp 325-337, issn 0009-7322Article

Lipoprotein(a) levels and risk of coronary heart disease in men : the lipid research clinics coronary primary prevention trialSCHAEFER, E. J; LAMON-FAVA, S; JENNER, J. L et al.JAMA, the journal of the American Medical Association. 1994, Vol 271, Num 13, pp 999-1003, issn 0098-7484Article

A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatinLEVY, R. I; TROENDLE, A. J; FATTU, J. M et al.Monograph - American Heart Association. 1993, Vol 87, Num 4, pp III.45-III.53, issn 0891-320X, 3Article

Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic menKRAUSS, R. M; LINDGREN, F. T; WILLIAMS, P. T et al.Lancet (British edition). 1987, Vol 2, Num 8550, pp 62-66, issn 0140-6736Article

Some clinical implications of the results of the lipid research clinics program prevalence studyLAROSA, J. C; LEVY, R. I; HAZZARD, W. R et al.Circulation. Supplement. 1986, Vol 73, Num 1, pp 126-133, issn 0069-4193Article

Thoughts on a Tahitian University in Higher Education in the PacificLEVY, R. I; LEVY, N. W; FAGU, M et al.Pacific Perspective. 1983, Vol 12, Num 1, pp 59-67, issn 0379-525XArticle